바이오 분석 시험 서비스 시장 규모, 점유율, 성장 분석 : 분자별, 시험별, 워크플로우별, 용도별, 최종 용도별, 지역별 - 업계 예측(2026-2033년)

Global Bioanalytical Testing Services Market size was valued at USD 4.18 Billion in 2024 and is poised to grow from USD 4.86 Billion in 2025 to USD 16.14 Billion by 2033, growing at a CAGR of 16.2% during the forecast period (2026-2033).

The global bioanalytical testing services market encompasses analytical offerings essential for pharmaceutical and biotech companies to evaluate the safety and efficacy of drugs and biologics. These services are vital during drug development and regulatory approval, focusing on measuring drug concentrations, metabolites, and biomarkers in biological samples such as blood, urine, and tissue. This market consists of contract research organizations (CROs) and other service providers that support the industry with reliable testing solutions. While the demand for accurate and dependable bioanalytical testing is increasing, the market faces challenges such as high service costs and a lack of standardization in methodologies. Addressing these barriers is crucial for ensuring the efficient progression of safe and effective therapeutic options to market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bioanalytical Testing Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bioanalytical Testing Services Market Segments Analysis

Global Bioanalytical Testing Services Market is segmented by Molecule, Test, Workflow, Application, End Use and region. Based on Molecule, the market is segmented into Small Molecule, Large Molecule and Others. Based on Test, the market is segmented into ADME, PK, PD, Bioavailability, Bioequivalence and Others. Based on Workflow, the market is segmented into Sample Preparation, Sample Analysis and Other Workflow Processes. Based on Application, the market is segmented into Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology and Other Applications. Based on End Use, the market is segmented into Pharma & BioPharma Companies, CDMO and CRO. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Bioanalytical Testing Services Market

The global bioanalytical testing services market is primarily driven by the increasing demand for drug development and approval processes, as pharmaceutical and biotechnology companies seek to ensure the safety and efficacy of their products. The rise in chronic diseases and the need for personalized medicine further fuel this demand, encouraging firms to invest in advanced testing methodologies. Additionally, regulatory agencies' stringent requirements for drug testing and bioanalytical validation amplify the market's growth. The integration of innovative technologies and automation in testing procedures also enhances efficiency, thereby attracting more organizations to outsource these specialized services.

Restraints in the Global Bioanalytical Testing Services Market

The considerable expenses linked to bioanalytical testing, particularly for advanced and specialized assessments, pose a significant challenge for the market. Such financial burdens can hinder the progress of small pharmaceutical companies and research institutions, limiting their ability to invest in necessary testing services. This financial strain may lead to reduced innovation and slower development timelines within the industry, as these smaller entities often operate on tighter budgets. Consequently, the high costs of bioanalytical testing can create obstacles that impact the overall growth and advancement of the global bioanalytical testing services market.

Market Trends of the Global Bioanalytical Testing Services Market

The Global Bioanalytical Testing Services market is experiencing significant growth driven by advances in biomarker discovery and development. As the focus shifts towards personalized medicine, the identification and validation of biomarkers have emerged as critical components in enhancing early diagnosis and enabling targeted therapies. This trend is further propelled by the integration of cutting-edge technologies and methodologies, allowing bioanalytical testing services to support the burgeoning demand for innovative treatments and diagnostic solutions. Consequently, the market is witnessing a robust expansion as companies seek to leverage these advancements to improve patient outcomes and streamline drug development processes.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Bioanalytical Testing Services Market Size by Molecule & CAGR (2026-2033)

• Market Overview
• Small Molecule
• Large Molecule
  • LC-MS Studies
  • Immunoassays
  • PK
  • ADA
  • Others
• Others

Global Bioanalytical Testing Services Market Size by Test & CAGR (2026-2033)

• Market Overview
• ADME
  • In-Vivo
  • In-Vitro
• PK
• PD
• Bioavailability
• Bioequivalence
• Others

Global Bioanalytical Testing Services Market Size by Workflow & CAGR (2026-2033)

• Market Overview
• Sample Preparation
  • Protein Precipitation
  • Liquid-Liquid Extraction
  • Solid Phase Extraction
• Sample Analysis
  • Hyphenated technique
  • Chromatographic technique
  • Electrophoresis
  • Ligand Binding Assay
  • Mass Spectrometry
  • Nuclear Magnetic Resonance
• Other Workflow Processes

Global Bioanalytical Testing Services Market Size by Application & CAGR (2026-2033)

• Market Overview
• Oncology
• Neurology
• Infectious Diseases
• Gastroenterology
• Cardiology
• Other Applications

Global Bioanalytical Testing Services Market Size by End Use & CAGR (2026-2033)

• Market Overview
• Pharma & BioPharma Companies
• CDMO
• CRO

Global Bioanalytical Testing Services Market Size & CAGR (2026-2033)

• North America (Molecule, Test, Workflow, Application, End Use)
  • US
  • Canada
• Europe (Molecule, Test, Workflow, Application, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Molecule, Test, Workflow, Application, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Molecule, Test, Workflow, Application, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Molecule, Test, Workflow, Application, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Charles River Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Labcorp Drug Development (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SGS S.A. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PPD, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICON plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syneos Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Q2 Solutions (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intertek Group plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parexel International Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ACM Global Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Frontage Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioAgilytix (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KCAS Bioanalysis & Biomarker Services (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific BioLabs (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations